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Role of clathrin in dense core vesicle biogenesis
ABSTRACT The dense core vesicles (DCVs) of neuroendocrine cells are a rich source of bioac-
tive molecules such as peptides, hormones, and neurotransmitters, but relatively little is 
known about how they are formed. Using fractionation profiling, a method that combines 
subcellular fractionation with mass spectrometry, we identified ∼1200 proteins in PC12 cell 
vesicle-enriched fractions, with DCV-associated proteins showing distinct profiles from pro-
teins associated with other types of vesicles. To investigate the role of clathrin in DCV biogen-
esis, we stably transduced PC12 cells with an inducible short hairpin RNA targeting clathrin 
heavy chain, resulting in ∼85% protein loss. DCVs could still be observed in the cells by elec-
tron microscopy, but mature profiles were approximately fourfold less abundant than in 
mock-treated cells. By quantitative mass spectrometry, DCV-associated proteins were found 
to be reduced approximately twofold in clathrin-depleted cells as a whole and approximate-
ly fivefold in vesicle-enriched fractions. Our combined data sets enabled us to identify new 
candidate DCV components. Secretion assays revealed that clathrin depletion causes a near-
complete block in secretagogue-induced exocytosis. Taken together, our data indicate that 
clathrin has a function in DCV biogenesis beyond its established role in removing unwanted 
proteins from the immature vesicle.
INTRODUCTION
Dense core vesicles (DCVs) are a type of regulated secretory granule 
packed with bioactive molecules such as hormones, neuropeptides, 
and catecholamines, which are found mainly in neurons and neuro-
endocrine cells. Although there has been interest in how molecules 
are trafficked to DCVs for more than 30 yr (Gumbiner and Kelly, 
1982; Moore et al., 1983), our knowledge of sorting signals and 
machinery for DCV trafficking is still relatively limited (Dikeakos and 
Reudelhuber, 2007). A role for clathrin was first proposed by Tooze 
and Tooze in 1986, on the basis of their observations that clathrin 
coats are frequently associated with immature DCVs in AtT-20 cells, 
an anterior pituitary-derived cell line (Tooze and Tooze, 1986). Sub-
sequent work by Klumperman and colleagues, on both DCVs and 
other types of secretory granules, showed that these clathrin-coated 
profiles were also positive for AP-1, the major adaptor for intracel-
lular clathrin-mediated trafficking, as well as for AP-1–dependent 
cargo proteins such as mannose 6-phosphate receptors, hydrolases, 
furin, and syntaxin 6, all of which are absent from the mature granule 
(Klumperman et al., 1998; Dittié et al., 1999). These findings led to 
the proposal that the role of the clathrin coat is to remove unwanted 
proteins from the nascent secretory granule, so that they can then 
be redirected to other parts of the cell.
Although there is no doubt that this is part of the story, several 
observations suggest that the situation may be somewhat more 
complicated. For instance, one of the few membrane proteins 
known to be associated with DCVs is phogrin, which has a dileucine 
sorting signal that binds to AP complexes, including AP-1. Mutating 
this sorting signal causes phogrin to be either retained in the Golgi 
region or mislocalized to the plasma membrane (Torii et al., 2005), 
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Electron micrographs of pellets 1, 2, and 3 are shown in Figure 
1B. Both CCVs (red arrows) and DCVs (blue arrows) can be easily 
identified in the first pellet, whereas the second and third pellets 
contain relatively few CCVs or DCVs and instead are enriched in 
smaller vesicles and other particles such as ribosomes and 
proteasomes.
To investigate the relative abundance of individual proteins in 
the three fractions, each of the three pellets was mixed with a third 
of the reference pellet and subjected to SDS–PAGE, then mass 
spectrometry was used to quantify the light-to-heavy ratio for every 
protein. In this way, individual distribution profiles of each protein 
across the subfractions were obtained. Because a visual representa-
tion of high-dimensional data is impractical to illustrate, we used 
principal component analysis (PCA) to achieve dimensionality 
reduction. Briefly, PCA derives linear combinations (“principal com-
ponents”) of the original variables that preserve a maximum of the 
information contained in the data, while reducing the overall num-
ber of variables. When applied to the fractionation profiling data 
set, principal components 1 and 2 accounted for 95% of the data 
variability. The structure of the data could hence be visualized in a 
2D scatter plot (Figure 1C and Supplemental Figure S1). As we ex-
pected, proteins known to be associated with CCVs, DCVs, and 
SMVs had similar profiles, and formed distinct clusters. Therefore 
fractionation profiling is a suitable and sensitive method for analyz-
ing several different types of PC12 cell vesicles simultaneously.
Clathrin knockdown in PC12 cells
Having established a fractionation profiling protocol for PC12 cells, 
we next investigated the effects of clathrin heavy chain depletion. 
The system that worked best in our hands was SMARTvector lentivi-
ral shRNA, in which the shRNA is inducibly coexpressed with green 
fluorescent protein (GFP) (Figure 2). Stably transduced cells were 
initially selected on the basis of puromycin resistance, then coex-
pression of GFP and shRNAs was induced by an overnight incuba-
tion with doxycycline. High GFP expressors were selected by flow 
cytometry, after which the cells were maintained in the absence of 
doxycycline because clathrin depletion compromises cell growth 
(Figure 2A). When doxycycline was added to the cells for 5 d, both 
immunofluorescence and Western blotting showed a robust loss of 
clathrin in the doxycycline-treated cells when compared with the 
mock-treated cells (Figure 2B). There was an even more dramatic 
loss of clathrin when we compared vesicle-enriched fractions from 
the two cell populations (Figure 2B). This is a common phenomenon 
(e.g., see Motley et al., 2003), and it appears to be because clathrin-
depleted cells attempt to form as many CCVs as control cells, but 
without sufficient clathrin they are unable to form a complete cage 
and thus vesicle budding is curtailed (Moskowitz et al., 2005; 
Hinrichsen et al., 2006).
What happens to DCVs in the clathrin-depleted cells? Electron 
microscopy showed that DCVs are still present (Figure 3A), but ma-
ture DCVs are relatively scarce (Figure 3, B and C). For instance, the 
most mature “type 1″ structures, which have only a dense core and 
no electron-lucent space, were depleted approximately fourfold in 
the knockdown cells, while the least mature “type 4″ structures, 
which consist mainly of an electron-lucent space with a relatively 
light core, were increased approximately twofold. The clathrin- 
depleted cells also contained unusual structures that we classified as 
“type 5.” The type 5 structures were somewhat larger than even 
immature DCVs, mainly electron-lucent, and contained small intralu-
menal inclusions that resembled the intralumenal vesicles of multi-
vesicluar bodies (MVBs). However, the type 5 organelles were 
smaller than MVBs, and unlike MVBs they were absent in the 
suggesting that APs and clathrin may be involved not only in traf-
ficking away from DCVs, but also in trafficking to DCVs. A further 
complication is that some of the cells that make DCVs also make 
synaptic-like microvesicles (SMVs). Like DCVs, SMVs are secreted in 
a regulated manner, and again clathrin has been invoked, although 
most likely in an endocytic capacity (Hannah et al., 1999). In addi-
tion, depleting clathrin and/or AP-1 in two other types of cells has 
been shown to completely abolish the formation of regulated secre-
tory organelles (Lui-Roberts et al., 2005; Burgess et al., 2011). Thus 
there is still a lack of understanding of the precise role of clathrin in 
DCV biogenesis.
One of the reasons progress has been slow is that it is difficult 
to carry out knockdowns in neuroendocrine cell lines, which are 
the best model system for investigating DCV formation and func-
tion. For instance, in a recent study by Eipper and colleagues 
on AtT-20 cells, short hairpin RNA (shRNA) was used to deplete the 
medium (μ1A) subunit of the AP-1 adaptor complex, resulting in a 
∼50% loss (Bonnemaison et al., 2014), as compared with the >90% 
protein loss routinely obtained in other cell types (Elbashir et al., 
2001). However, even with only a 50% loss, there was a clear phe-
notype, with secretagogue-induced release of DCV proteins also 
down by ∼50% (Bonnemaison et al., 2014). Other groups have 
made use of dominant negative constructs to investigate the func-
tion of clathrin and associated proteins in DCV biogenesis. Over-
expressing the clathrin “hub” in pancreatic beta cells caused an 
increase in the proteolysis of insulin, consistent with a defect in the 
removal of unwanted lysosomal hydrolases from immature vesicles 
(Molinete et al., 2001); and overexpressing a truncated version of 
GGA1 (another clathrin adaptor) in PC12 (adrenal medulla–
derived) cells also strongly affected DCV maturation (Kakhlon 
et al., 2006). However, one problem with dominant negative ex-
periments is that the phenotype may be indirect. For instance, the 
truncated forms of clathrin and GGA1 that were used in the two 
studies bind to Hip1R and to Arf1, respectively (Bennett et al., 
2001; Puertollano et al., 2001), so it is possible that the block in 
DCV maturation might have been due to a lack of Hip1R or Arf1, 
rather than because clathrin or GGA1 are directly involved.
We decided to revisit the role of clathrin in DCV biogenesis using 
two new approaches: fractionation profiling and induced shRNA 
knockdown. Fractionation profiling was developed by our labora-
tory as a means of identifying proteins associated with different 
types of subcellular structures (Borner et al., 2014). Our aim was first 
to apply this method to PC12 cells to find out whether we could 
distinguish between clathrin-coated vesicles (CCVs), DCVs, and 
SMVs, and then to look for changes in the behavior of the different 
types of proteins when clathrin was depleted.
RESULTS
Fractionation profiling of PC12 cells
We began by developing a protocol for fractionation profiling in 
PC12 cells, shown schematically in Figure 1A. Briefly, cells were grown 
in stable isotope labeling with amino acids in cell culture (SILAC) 
“light” or SILAC “heavy” medium for 3 wk, by which time incorpora-
tion of heavy amino acids into proteins was found to be ∼94%. Both 
sets of cells were homogenized and a vesicle-enriched fraction was 
obtained by differential centrifugation (see Materials and Methods). 
Then the “light” vesicle-enriched fraction was subjected to three suc-
cessive centrifugation steps, collecting the pellets at the end of each 
spin and then recentrifuging the supernatants at a higher g-force. The 
“heavy” vesicle-enriched fraction was only centrifuged once, at a high 
g-force, to provide a reference pellet to compare with the three 
“light” pellets.
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Comparative proteomics
To look for differences in the protein compo-
sition of DCVs in clathrin-depleted cells, we 
first analyzed total homogenates and vesi-
cle-enriched fractions from SILAC-labeled 
mock-treated and doxycycline-treated cells. 
Consistent with our Western blotting results 
(Figure 2B), clathrin heavy chain was more 
strongly depleted from the vesicle-enriched 
fractions than from the cells as a whole (∼13-
fold vs. ∼7-fold). Other CCV components 
such as AP-1 were not depleted from the 
cells as a whole, only from the vesicle- 
enriched fractions, consistent with our work 
on HeLa cells (Borner et al., 2006).
Interestingly, however, when we com-
pared DCV proteins, we saw a modest but 
reproducible depletion from the cells as a 
whole (∼1.5 to 2-fold), as well as a more 
pronounced loss from the vesicle-enriched 
fractions (∼4- to 6-fold). These results indi-
cate that at steady state, in the clathrin- 
depleted cells DCV proteins are not only 
less abundant but also differentially local-
ized. SMV proteins were unaffected in the 
cell as a whole, but ∼1.5- to 2-fold depleted 
in the vesicle-enriched fractions.
By combining the fractionation profiling 
and clathrin knockdown data and analyzing 
the entire data set by PCA (Figure 4B), it was 
possible to identify other proteins that be-
haved in a similar manner to known DCV 
proteins, making them good candidates for 
additional DCV components. For instance, 
Emilin-1 (elastin microfibril interface–located 
protein 1) is a secreted protein not found in 
HeLa cells, which cofractionated with DCVs 
and was strongly affected by clathrin knock-
down. Other novel candidate DCV proteins 
include Igfbp6 (insulin-like growth factor 
binding protein 6), Hapln4 (hyaluronan and 
proteoglycan link protein 4), Tprg1L (tumor 
protein p63–regulated 1–like), and Pnma2 
(paraneoplastic antigen Ma2) (Supplemen-
tal Figure S2).
Fate of DCV components in 
clathrin-depleted cells
What happens to DCV proteins when clath-
rin is depleted? To investigate whether 
they are still secreted in a regulated man-
ner, we collected culture medium from cells 
that had been washed and then treated for 
15 min either with or without BaCl2, a stan-
dard secretagogue. Both the collected me-
dium and the cell homogenates were then 
subjected to Western blotting and probed 
with an antibody against chromogranin B 
(CgB) (Figure 5A). These experiments 
showed a dramatic decrease in BaCl2-induced release of CgB in 
the clathrin-depleted cells, while the basal or constitutive release 
(i.e., in the absence of BaCl2) looked roughly similar, indicating 
mock-treated cells. We suspect that they may be similar to the vacu-
oles observed by Eipper and coworkers in μ1A-depleted AtT-20 
cells (Bonnemaison et al., 2014).
FIGURE 1: Fractionation profiling of PC12 cells. (A) Schematic diagram of the protocol. Cells 
that had been grown for 3 wk in either SILAC light or SILAC heavy medium were homogenized 
and a vesicle-enriched fraction was prepared. The vesicle-enriched fraction from cells grown in 
light medium was then subjected to three successive centrifugation steps at increasing g-force 
to generate three separate pellets. The vesicle-enriched fraction from cells grown in heavy 
medium was centrifuged only once, at high g-force, to provide the reference pellet. (B) Electron 
micrographs of the three SILAC light pellets. Pellet 1 contains the majority of the clathrin-coated 
vesicles (CCVs; red arrows) and the dense core vesicles (DCVs; blue arrows). Scale bar: 200 nm. 
(C) Each of the three pellets was mixed with a third of the reference pellet and analyzed by mass 
spectrometry to quantify the light-to-heavy ratio for every protein; then the data were subjected 
to principal component analysis (PCA; the axes show principal components 1 and 2). Proteins 
associated with the three types of vesicles form distinct clusters because of their similar 
vesicle-specific and consistent fractionation profiles. Individual protein identities are shown in 
Supplemental Figure S1.
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first incubated cells for 3 h in medium con-
taining [3H]norepinephrine (Figure 6A). The 
cells were then washed and incubated for 
15 min either with or without BaCl2, the cul-
ture supernatants were collected, the cells 
were lysed, and the radioactivity present in 
both supernatants and lysates was quanti-
fied by scintillation counting. Adding the 
values together provided a measure of to-
tal [3H]norepinephrine uptake under each 
condition.
Uptake of [3H]norepinephrine was found 
to be approximately fivefold reduced in the 
clathrin-depleted cells when compared 
with equal numbers of mock-treated cells 
(Figure 6B). In the absence of BaCl2, ∼4% 
of the [3H]norepinephrine was released 
from mock-treated cells, while BaCl2 treat-
ment caused a ∼12-fold increase in [3H]nor-
epinephrine release (Figure 6C). In contrast, 
in the clathrin-depleted cells, ∼10% of the 
[3H]norepinephrine was released into the 
culture supernatant in the absence of 
BaCl2, and there was no significant increase 
when cells were incubated in the presence 
of BaCl2. Thus clathrin depletion causes 
PC12 cell DCVs to become essentially inca-
pable of secretagogue-induced catechol-
amine release.
To ensure that the phenotype we observed was not an off-target 
effect, we first tried stably transfecting our inducible cell line with a 
tagged shRNA-resistant clathrin heavy chain construct. Unfortu-
nately, even our most highly expressing cells were not making 
enough clathrin for a rescue (Supplemental Figure S3, A–D). There-
fore we tried an alternative approach: use of a second independent 
shRNA, shRNA-B. Although the knockdowns were not as effective 
as with our other shRNA (shRNA-A), we observed qualitatively simi-
lar effects on [3H]norephrine uptake and release. We think that the 
reason we got only a partial block in secretagogue-induced exocy-
tosis, instead of a complete block, can be explained by the coopera-
tive nature of clathrin assembly. Whereas shRNA-A most likely 
reduced the amount of clathrin to below the critical concentration 
needed to form a CCV (Moskowitz et al., 2005), shRNA-B reduced it 
to the extent that CCV formation was impaired but not abolished.
DISCUSSION
Clathrin has long been implicated in DCV biogenesis, but there are 
still questions about its precise role. In the present study, we have 
combined fractionation profiling, inducible clathrin knockdown, and 
morphological and biochemical assays, to try to understand how 
clathrin contributes to the formation and function of DCVs in PC12 
cells.
Fractionation profiling is a method we originally developed in 
HeLa cells and then applied to Drosophila S2 cells (Borner et al., 
2014). It was designed to optimize the segregation of CCVs from 
other subcellular particles, but the present study shows that it also 
provides good resolution of DCVs, which like CCVs are fairly uni-
form in size and density. Even though CCVs and DCVs are both 
most concentrated in fraction 1 (see Figure 1), their distinct profiles 
mean that they can be well separated by PCA.
We were able to optimize clathrin knockdown using a lentiviral 
system that allows inducible coexpression of shRNA and GFP. This 
that regulated secretion is severely impaired in the clathrin- 
depleted cells.
To obtain more quantitative data, we turned to comparative pro-
teomics. Cells were grown in either heavy or light medium for 3 wk, 
and for the last 5 d doxycycline was added to half of the “heavy” 
cells and half of the “light” cells in order to deplete clathrin (Figure 
5B). All of the cells were washed, and then the heavy cells were in-
cubated for 15 min with BaCl2 and the light cells without BaCl2. The 
four sets of culture supernatants were collected, and the two super-
natants from the mock-treated cells were pooled, as were the 
two supernatants from the clathrin-depleted cells. CgB was then 
immunoprecipitated from the mixed supernatants. Using mass 
spectrometry to calculate the heavy-to-light ratios, we were able to 
determine the relative amounts of constitutive versus regulated se-
cretion in mock-treated and clathrin-depleted cells. In the mock-
treated cells, there was ∼10 times as much CgB secreted into the 
culture supernatant in the presence of BaCl2 as in the absence of 
BaCl2. However, in the clathrin-depleted cells, there was almost no 
increase in CgB secretion in the presence of BaCl2 (1.164 ± 0.113). 
This indicates that the block in DCV maturation into functional 
organelles is much more severe than that indicated by electron 
microscopy, where morphologically recognizable mature DCVs 
were reduced fourfold. The secretion experiments suggest that, in 
fact, almost none of the DCVs are capable of regulated exocytosis.
Norepinephrine uptake and release
A well-established assay for DCV function is to measure the uptake 
and release of a catecholamine such as norepinephrine (Taupenot, 
2007). The DCV membrane contains a monoamine transporter, 
VMAT1, which efficiently concentrates catecholamines, and the cat-
echolamines are then released into the medium when the cells are 
treated with a secretagogue such as BaCl2. To investigate whether 
clathrin depletion alters catecholamine uptake and/or release, we 
FIGURE 2: Clathrin depletion from PC12 cells. (A) Cells were transduced with SMARTvector 
lentiviral shRNA targeting clathrin heavy chain (CHC). Infected cells were initially selected with 
puromycin. Then, because the shRNA is inducibly coexpressed with GFP, treatment with 
doxycycline overnight was used to induce expression. The doxycycline was then removed and 
high expressors were isolated by flow cytometry to provide a stable population of cells 
harboring inducible CHC shRNA. (B) To investigate the effects of clathrin depletion, the cells 
were either mock-treated or treated for 5 d with doxycycline. Immunofluorescence and Western 
blotting both show a robust loss of clathrin. EF2 was used as a loading control. Scale bar: 10 μm.
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system not only works much better on PC12 cells than siRNA 
transfection, it also has several other advantages. First, because 
the cells are stably transduced, scaling up for large-scale bio-
chemistry experiments is much cheaper than when oligonucle-
otides and transfection reagents are used. Second, because 
expression of the shRNA is inducible, there is less of a problem 
with cell viability (always a concern when knocking down clathrin). 
Third, because the starting populations of cells are identical, vari-
ability between control and knockdown cells is minimized. Fourth, 
because the shRNA is coexpressed with GFP, efficiency of induc-
tion can be monitored by fluorescence microscopy of living cells. 
We found that we were routinely getting >95% of the cells 
expressing GFP.
One outcome of combining fractionation profiling and clathrin 
depletion was that it allowed us to identify new candidate DCV 
proteins, because these proteins not only had similar profiles to 
known DCV proteins, but also were strongly depleted from the 
vesicle- enriched fraction after clathrin knockdown. One such pro-
tein, Emilin-1, has been shown to be an inhibitor of TGF-β signal-
ing, and mice lacking this protein are susceptible to high blood 
pressure, similar to CgA- and CgB-deficient mice (Litteri et al., 
2012). Furthermore, polymorphisms in the human EMILIN1 gene 
FIGURE 3: Electron microscopy of mock-treated and clathrin-depleted cells. (A) Representative 
images of the mock-treated and clathrin-depleted cells, with CCVs indicated in red and DCVs in 
blue. Scale bar: 500 nm. (B) Classification of different types of DCVs. Type 1 are the most mature 
and type 4 are the least mature. The type 5 vesicles were only seen in clathrin-depleted cells. 
Scale bar: 200 nm. (C) Quantification of the different vesicle types. Type 1 vesicles were 
approximately fourfold reduced in the clathrin-depleted cells. Total vesicle counts were 126 for 
control and 133 for clathrin knockdown.
have been found to correlate with hyper-
tension, suggesting that Emilin-1 may be a 
DCV cargo protein with clinical relevance 
(Shimodaira et al., 2010).
When we examined our cells by electron 
microscopy, we observed more immature 
and fewer mature DCVs in clathrin-depleted 
PC12 cells, consistent with the well-docu-
mented role for clathrin in DCV maturation. 
However, although typical-looking mature 
(“type 1″) DCVs could be observed by elec-
tron microscopy in clathrin-depleted cells 
(albeit at a fourfold reduced frequency), 
our results indicate that these DCVs are 
highly impaired functionally. Secretagogue-
induced release of both CgB and norepi-
nephrine was essentially abolished in the 
clathrin-depleted cells. Norepinephrine up-
take was also reduced, by approximately 
fivefold, even though there was only approx-
imately a twofold reduction in VMAT (the 
monoamine transporter) in the vesicle-en-
riched fraction. This observation suggests 
that there is likely to be missorting of other 
proteins involved in the sequestration of nor-
epineprine into DCVs as well. Furthermore, 
the near-complete insensitivity of the cells to 
BaCl2 indicates that there is also mislocaliza-
tion of DCV-associated proteins involved in 
regulated exocytosis. For instance, there 
might be insufficient amounts of machinery 
such as SNAREs and synaptotagmins. One 
caveat is that regulated exocytosis involves 
the plasma membrane as well as the DCV, so 
at present we cannot rule out the possibility 
that the resistance to secretagogue in the 
clathrin-depleted cells may have been due 
at least in part to changes in the composition 
of the plasma membrane. Similarly, the rela-
tively modest but reproducible loss of SMV 
proteins from the vesicle-enriched fraction after clathrin knockdown 
could be due to effects on clathrin-mediated endocytosis rather than 
intracellular trafficking (Saheki and De Camilli, 2012).
Previous studies making use of knockdowns and dominant nega-
tive constructs have demonstrated that clathrin and associated pro-
teins play a role in DCV biogenesis (Molinete et al., 2001; Kakhlon 
et al., 2006; Bonnemaison et al., 2014), but the phenotypes that 
were reported were less severe than those we have found in the 
present study, possibly because protein loss was less complete. 
However, knockdown and dominant negative studies on two other 
types of regulated secretory organelles, the Weibel-Palade bodies 
(WPBs) of endothelial cells (Lui-Roberts et al., 2005) and the glue 
granules of Drosophila salivary gland epithelial cells (Burgess et al., 
2011), showed that interfering with clathrin and/or AP-1 completely 
abolished WPB and glue granule formation. Although these other 
organelles differ in some respects from DCVs (e.g., the immature 
WPB is partially or completely wrapped in an AP-1- and clathrin-
positive coat [Lui-Roberts et al., 2005]), nevertheless there are 
precedents for clathrin having a function in the regulated secretory 
pathway above and beyond its established role in facilitating organ-
elle maturation by removing unwanted proteins. One drawback of 
RNAi knockdowns, as well as gene knockouts, is that several days or 
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number 10) were used for all experiments. For routine maintenance, 
the cells were grown in T25 flasks (Nunc, USA) in DMEM GlutaMAX 
(Invitrogen), supplemented with 10% heat-inactivated horse serum, 
5% heat-inactivated fetal bovine serum, 100 U/ml penicillin G, and 
100 μg/ml streptomycin (Life Technologies, USA). The cells were 
grown in 5% CO2 at 37°C in a humidified incubator, and were pas-
saged every 4–5 d or when confluent.
SILAC labeling
For SILAC experiments, PC12 cells were cultured in SILAC medium 
for 3 wk to achieve metabolic labeling. The medium consisted of 
DMEM (Thermo Fisher) supplemented with 5% (vol/vol) fetal bovine 
serum (10,000 MW cutoff; Invitrogen), plus 10% (vol/vol) dialyzed 
horse serum (10,000 MW cutoff; Dundee Cell), and either “heavy” 
amino acids (l-arginine-13C615N4:HCl (50 mg/l) and l-lysine-
13C615N2:2HCl (100 mg/l) or “light” amino acids (Cambridge Iso-
tope Laboratories). The average incorporation efficiency was ∼94%, 
as determined by mass spectrometry.
Vesicle-enriched fraction
Two confluent 500-cm2 dishes of PC12 cells were scraped into 
∼10 ml buffer A (0.1 M MES, pH 6.5 [adjusted with NaOH], 0.2 mM 
EGTA, 0.5 mM MgCl2). The cells were homogenized with a motor-
ized Potter-Elvehjem homogenizer (25 strokes), syringe-disrupted 
using a 21G × 2″ (BD Microlance) needle, and centrifuged at ∼4100 × 
g for 32 min. Supernatants were treated with 50 μg/ml ribonuclease 
A for 60 min at 4°. Partially digested ribosomes were pelleted by 
centrifugation (∼4100 × g for 3 min), and discarded. The resultant 
supernatants were pelleted by centrifugation at 55,000 rpm (209,717 
× g RCFmax) for 40 min in an MLA-80 rotor (Beckman Coulter). Pellets 
were resuspended in ∼800 μl buffer A using a 1 ml Dounce homog-
enizer, and mixed with an equal volume of FS buffer (12.5% [wt/vol] 
Ficoll, 12.5% [wt/vol] sucrose, in buffer A). All subsequent centrifuga-
tion steps were performed using a TLA-110 rotor (Beckman Coulter). 
Samples were spun at 20,000 rpm (21,720 × g RCFmax) for 34 min to 
pellet the bulk of the membranes (pellet discarded). Supernatants 
were diluted with four volumes of buffer A, and were centrifuged at 
35,000 rpm (66,542 × g RCFmax) for 30 min to obtain the vesicle-en-
riched fraction (pellet). All preparations were performed at 4°C.
Fractionation profiling
Fractionation profiling, a method for combining differential centrifu-
gation with quantitative mass spectrometry to resolve different 
types of subcellular particles, was carried out essentially as previ-
ously described (Borner et al., 2014). A vesicle-enriched fraction was 
prepared as above, but after diluting the supernatant from the 
20,000 rpm spin, samples were first centrifuged at 66,500 × g 
(35,000 rpm, TLA-110) for 20 min, to obtain the 35K fraction pellet. 
The supernatant was transferred to a fresh centrifuge tube, mixed 
by pipetting, and centrifuged at 89,000 × g (45,000 rpm, TLA-110) 
for 20 min, to obtain the 45K fraction pellet. The supernatant was 
again transferred to a fresh tube, and centrifuged at 190,000 × g 
(60,000 rpm, TLA-110) for 40 min to obtain the final 60K fraction 
pellet. To prepare the reference fraction, the diluted supernatant 
after the Ficoll/sucrose step was spun at 190,000 × g (60,000 rpm, 
TLA-110) for 40 min. Pellets were resuspended in 1× NUPAGE LDS 
buffer, using 20 μl for the pellets from the three successive spins and 
60 μl for the reference pellet.
Sample preparation for mass spectrometry
Each of the three subfractions (35K, 45K, and 60K) was combined 
with one-third of the reference sample, dithiothreitol (DTT) was 
even weeks elapse between the initiation of depletion or deletion 
and the analysis of the phenotype, so some of the observed effects 
may be indirect. Thus more rapid methods for protein removal, such 
as knocksideways (10 min [Robinson et al., 2010; Willox and Royle, 
2012]) or induced oligomerization (2 h [Moskowitz et al., 2003; Zlatic 
et al., 2013]), may provide further insights into the precise role of 
clathrin in DCV biogenesis.
MATERIALS AND METHODS
PC12 cell culture
Rat pheochromocytoma PC12 cells were a gift from Nitish Mahapa-
tra, IIT Madras. Early passage cells (i.e., no greater than passage 
FIGURE 4: Effect of clathrin depletion on different types of vesicles. 
(A) Mass spectrometry was carried out on SILAC-labeled mock-
treated and clathrin-depleted cell homogenates and vesicle-enriched 
fractions to identify proteins with altered behavior. More than 2500 
proteins were quantified, of which a few examples are shown here. 
CCV-associated proteins (shown in red) were depleted from the 
vesicle-enriched fraction, but with the exception of clathrin they were 
not depleted from the cell homogenate. DCV-enriched proteins 
(shown in blue) were depleted 1.5- to 2-fold from the cell homogenate 
and 4- to 6-fold from the vesicle-enriched fraction, while SMV proteins 
(green) were unaffected in the homogenate but moderately depleted 
from the vesicle-enriched fraction. Other proteins (shown in black) 
were generally unaffected. Proteins are indicated by their gene names 
(Cltc = clathrin heavy chain; Clint1 = epsinR; Ap1m1 = AP-1 μ1; Scg2 = 
secretogranin II; Chgb = chromogranin B; Ptprn = receptor-type 
tyrosine-protein phosphatase-like N; Syp = synaptophysin; Sv2a = 
synaptic vesicle glycoprotein 2A; Vamp2 = VAMP2; Psma4 = 
proteasome subunit alpha 4; Tubb2a = tubulin beta 2A; Eef2 = 
eukaryotic translation elongation factor 2). Error bars show SD (n = 3). 
(B) Principal component analysis combining the fractionation profiling 
data shown in Figure 1C and the data shown above on fold-depletion 
in the vesicle-enriched fraction after clathrin knockdown (three 
replicates). CCVs and DCVs are well separated, and new DCV 
components can be predicted, such as Emilin (circled). The identities 
of the protein are shown in Supplemental Figure S2.
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FIGURE 5: Secretion of chromogranin B (CgB) in mock-treated and clathrin-depleted cells. 
A. Western blot of mock-treated and clathrin-depleted cells incubated for 15 min in the 
presence or absence of the secretagogue BaCl2, after which both the cells and the culture 
supernatants were probed with anti-CgB. Clathrin depletion strongly reduces induced secretion 
of CgB. (B) Both mock-treated and clathrin-depleted cells were grown in both SILAC heavy and 
SILAC light medium; then the heavy and light cells were incubated for 15 min with or without 
BaCl2, respectively. Heavy and light media were pooled, immunoprecipitated with anti-CgB, and 
analyzed by mass spectrometry. In the mock-treated cells, BaCl2 caused a (9.59 ± 1.47)-fold 
increase in CgB secretion. However, in the clathrin-depleted cells, the increase was negligible 
(1.16 ± 0.11). The indicated p value is derived from a two-tailed Student’s test (four biological 
replicates).
enabled. Alternatively, data were processed 
in Proteome Discoverer 1.4 using Sequest 
to search a Uniprot R. norvegicus database 
(downloaded 7 April 2014; 27,344 entries). 
Oxidized methionine, 13C615N2 lysine, and 
13C615N4 arginine were set as variable modi-
fications and carbamidomethyl cysteine as a 
fixed modification. False discovery rate cal-
culations were performed by Percolator and 
quantification by the Precursor ion quanti-
fier node. Where indicated, ratios were 
normalized on protein median. The raw 
data files were processed using MaxQuant 
(with requantify and match between runs 
features enabled). The primary output for 
each SILAC comparison was a list of identi-
fied proteins, a ratio of relative abundance 
(heavy/light ratio), and the number of quan-
tification events (count). Each MaxQuant 
output file was formatted in an identical 
manner: reverse hits, proteins identified 
only by site, common contaminants, and 
proteins with no gene name were removed. 
The SILAC ratios are shown in Supplemen-
tal Table S1.
To identify proteins with similar fraction-
ation profiles, PCA was performed as previ-
ously described (Borner et al., 2012). Briefly, 
the ratio data were logarithmically trans-
formed, precentered, and correlated using 
SIMCAS 14.0 (Umetrics), which was also 
used to generate the scatter plots.
Proteins were assigned to DCVs, CCVs, 
or SMVs according to the following litera-
ture: Winkler, 1993; Parmer et al., 1997; 
Wegrzyn et al., 2007, 2010; Wimalasena, 
2011; and Borges et al., 2013, for DCVs; 
Borner et al., 2012, 2014, for CCVs; and 
Takamori et al., 2006 for SMVs.
Generation of inducible shRNA-expressing stable cell lines
Clathrin knockdowns were carried out using the SMARTvector rat 
lentiviral shRNA system (Dharmacon), in which shRNAs targeting a 
gene of interest are inducibly coexpressed with GFP. PC12 cells 
were plated in polylysine-coated six-well plates and trans-
duced with virions encoding three different targeting constructs 
(VSR6432-223531394), according to the manufacturer’s protocol. 
Cells containing integrated lentiviral sequences were selected 
using puromycin (5 μg/ml), replacing the medium every 3 d until 
resistant colonies were observed. Cells were then induced with 
doxycycline at 1 μg/ml overnight, and highly GFP-positive cells 
were obtained by flow cytometry. The cells were then maintained 
in medium containing puromycin but without doxycycline. Out of 
the three constructs, V2IRNMCG_2797855 (“shRNA-A”) was most 
effective at depleting clathrin and was used for all subsequent ex-
periments. For the experiments shown in Supplemental Figure S3, 
we used one of the other shRNAs, V2IRNMCG_2797847 (“shRNA-
B”). We also attempted to rescue the cells with an mCherry-tagged 
version of clathrin heavy chain that contained silent mutations to 
make it resistant to shRNA-A. Stably transfected cells were se-
lected using 1 mg/ml G418, and high expressors were identified 
by fluorescence microscopy and flow cytometry. Unfortunately, 
added to a final concentration of 50 mM, and samples were incu-
bated at 90°C for 3 min. The samples were then subjected to gel 
electrophoresis, using NUPGAE precast gradient gels (Invitrogen). 
The gels were stained with SimplyBlue SafeStain (Thermo Fisher), 
and each lane was cut into eight slices. Thus a routine fractionation 
profiling experiment yielded 24 samples, which were then analyzed 
by mass spectrometry.
Mass spectrometry LC-MS/MS and data processing
SDS–PAGE resolved proteins were reduced, alkylated, and digested 
in-gel with trypsin, and then the resulting peptides were concen-
trated and desalted using Stage tips (Antrobus and Borner, 2011). 
Tryptic peptides were analyzed by LC-MS/MS using a Q Exactive 
coupled to an RSLCnano3000 UHPLC (Thermo Fisher). Peptides 
were resolved using a 50-cm EASY-Spray PepMap C18 column 
(Thermo Fisher) with data acquired in a data-dependent acquisition 
manner. Data were processed using MaxQuant 1.3.0.5 using An-
dromeda to search a Uniprot Rattus norvegicus database (down-
loaded 7 April 2014, 27,344 entries) with Homo sapiens AP1G1 
(O43747) added. N-terminal protein acetylation and methionine 
oxidation were set as variable modifications, carbamidomethyl 
cysteine set as a fixed modification, and both LFQ and iBAQ were 
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immunofluorescence, Alexa Fluor-conju-
gated secondary antibodies were obtained 
from Invitrogen, and images were captured 
using a LSM880 confocal microscope at 63× 
magnification.
Electron microscopy
Electron microscopy was carried out on 
both subcellular fractions and cultured cells. 
Pelleted fractions were fixed with 2% para-
formaldehyde/2.5% glutaraldehyde in 0.1 
M cacodylate buffer, pH 7.2, at room tem-
perature for 30 min, washed with 0.1 M 
cacodylate buffer, and postfixed using 1% 
osmium tetroxide for 1 h. Pellets were then 
washed before being incubated with 1% 
tannic acid in 0.05 M cacodylate buffer, pH 
7.2, for 40 min to enhance contrast, and 
then dehydrated in ethanol and embedded 
in Araldyte CY212 epoxy resin (Agar Scien-
tific, Stansted, UK). Cultured cells were 
grown on plastic dishes and fixed using 2% 
paraformaldehyde, 2.5% glutaraldehyde, 
and 0.1 M cacodylate buffer, pH 7.2. The 
cells were then scraped and pelleted, post-
fixed with 1% osmium tetroxide, incubated 
with 1% tannic acid to enhance contrast, 
and dehydrated using increasing concentra-
tions of ethanol before being embedded in 
epoxy resin in beam capsules and cured 
overnight at 65°C. For both types of sam-
ples, ultrathin (50–70 nm) conventional sec-
tions were cut using a diamond knife 
mounted onto a Reichart ultracut S ultrami-
crotome and collected onto copper grids. 
The grids were stained using lead citrate, 
and sections were viewed on a FEI Tecnai 
transmission electron microscope at a work-
ing voltage of 80 kV.
Quantification of electron microscopy
Pellets of cells ensured random distribution 
of organelles between cells on each sec-
tion. High-magnification images were taken 
of every part of six cells per condition, and 
the cytosolic area was calculated by remov-
ing nuclear area from the total cellular area. 
Vesicles were categorized by phenotype, 
where type 1 are most mature and type 4 
least mature. The type 5 vesicles were only seen in clathrin-de-
pleted cells. Type 1 vesicles contained a dense and condensed 
core, with no electron-lucent lumen. Type 2 vesicles contained a 
dense core but were surrounded by a thin electron-lucent lumen. 
Type 3 vesicles contained mostly electron-lucent lumens but also 
contained a small dense patch. Type 4 vesicles were lumenal vesi-
cles with little or no density. Type 5 vesicles were only seen in 
clathrin-depleted cells and displayed as vesicles with large elec-
tron-lucent lumens that occasionally contained small cores. These 
vesicles were the largest and often appeared in clusters. Clathrin 
depletion reduced the number of vesicles per area of cytosol 
(mock cells: 0.587 vesicles/μm2; clathrin-depleted cells: 0.357 
vesicles/μm2).
however, we were unable to get sufficiently high expression for a 
rescue.
Antibodies, Western blotting, and immunofluorescence
Antibodies used in this study include an in-house rabbit polyclonal 
antibody against clathrin heavy chain (Simpson et al., 1996), goat 
antibodies against EF2 and CgB (Santa Cruz Biotechnology), and rat 
monoclonal anti-RFP (5F8, ChromoTek). For Western blotting, 
horseradish peroxidase–conjugated secondary antibodies were ob-
tained from Sigma Aldrich, ECL Plus Western Blotting Detection 
System (GE Healthcare Amersham) was used as the developing 
agent, the blots were exposed to Super RX film (Fuji, UK), and im-
ages were acquired using an Epson Perfection 1650 scanner. For 
FIGURE 6: Uptake and secretion of [3H]norepinephrine in mock-treated and clathrin-depleted 
cells. (A) Schematic diagram of the protocol. Mock-treated and clathrin-depleted cells were 
incubated for 3 h with [3H]norepinephrine, then washed and incubated for 15 min either with or 
without BaCl2. Radioactivity in the cells and in the culture supernatant was determined by 
scintillation counting. (B) Adding up the counts in both cells and medium showed that there was 
approximately fivefold more uptake in the mock-treated cells. **Indicates statistical significance 
at the p < 0.005 level assessed by two-tailed Student’s t test (three biological replicates). (C) In 
the mock-treated cells, release of [3H]norepinephrine was strongly dependent on BaCl2, but in 
the clathrin-depleted cells, the effect of BaCl2 was insignificant. **Indicates statistical 
significance at the p < 0.005 level assessed by analysis of variance with Tukey’s post-hoc test; 
n.s. indicates lack of statistical significance at the p < 0.05 level (three biological replicates).
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were then collected, and the cells were lysed in lysis buffer. Both the 
supernatants and the lysates were mixed with liquid scintillation 
cocktail, and radioactivity was quantified using a Beckman liquid 
scintillation counter. The experiments shown in Figure 6 are biologi-
cal replicates, carried out three times independently, while those in 
Supplemental Figure S3 are technical replicates, carried out in tripli-
cate on the same day.
Vesicle-enriched fractions from mock-treated and 
clathrin-depleted cells
Cells grown in either SILAC heavy or SILAC light medium were 
plated in two 500 cm2 dishes. One pair of dishes was treated with 
1 μg/ml doxycycline for 5 d to induce knockdown, while the other 
pair of dishes served as the mock-treated control. Label swapping 
was carried out to ensure that any differences observed were due to 
the presence or absence of clathrin. Thus, in one set of experiments, 
the clathrin-depleted cells were incubated in light medium and the 
mock-treated cells in heavy medium, while in a second set of experi-
ments, the clathrin-depleted cells were incubated in heavy medium 
and the mock-treated cells in light medium. An additional control 
experiment was carried out in which clathrin- depleted cells were 
incubated in heavy medium, and cells transduced with a nontarget-
ing shRNA were incubated in light medium and induced with doxy-
cycline. This was to ensure that effects of doxycycline were due to 
clathrin depletion rather than to other targets of the drug.
Vesicle-enriched fractions from heavy- and light-labeled cells 
were prepared as described above, and pellets were resuspended 
in 50 μl of nonreducing SDS–PAGE buffer (4% [wt/vol] SDS, 10 mM 
Tris-HCl, pH = 8.0), heated to 65°C for 3 min, and centrifuged at 
16,000 × g for 1 min to remove insoluble material. Protein concen-
trations were estimated with a BCA assay (Pierce). Equal amounts of 
protein from two complementary samples were then pooled, ad-
justed with 1:3 volumes of 4× sample buffer (10% [wt/vol] SDS, 40% 
[vol/vol] glycerol, 8% [vol/vol] 2-mercaptoethanol, 200 mM Tris-HCl, 
pH = 6.8), heated to 90°C for 3 min, and subjected to SDS–PAGE. 
In-gel digestion and mass spectrometry were carried out as 
described above.
Secretion of CgB
Time-dependent secretion experiments were carried out to follow 
the fate of CgB, both by Western blotting (see above) and by SI-
LAC-based mass spectrometry. For the mass spectrometry experi-
ments, 10-cm dishes of cells were grown in either heavy or light 
medium, then clathrin knockdown was induced in half of the dishes 
by treating with doxycycline for 5 d, as described above. The me-
dium was removed and the cells were washed twice with release 
buffer (150 mM NaCl, 5 mM KCl, 2 mM CaCl2,10 mM HEPES, pH = 
7). Then the cells grown in light medium were incubated for 15 min 
at 37°C in release buffer, while the cells grown in heavy medium 
were incubated for 15 min at 37°C in stimulation buffer, which has 
the same composition as release buffer but contains 5 mM BaCl2 
and lacks CaCl2. The two supernatants from the mock-depleted 
cells were then pooled together, and the two supernatants from the 
clathrin-depleted cells were also pooled together, then each pooled 
sample was concentrated down to 1 ml using an Amicon filter with 
a 3 kDa cutoff. Both sets of samples were immunoprecipitated with 
goat anti-CgB antibody using a standard protocol (Seaman, 2004). 
Briefly, the samples were precleared and incubated with the anti-
body overnight (1.6 μg in 24 ml), then the antibody and its bound 
antigen were captured onto protein G Sepharose beads. The beads 
were vacuum dried, suspended in 40 μl 2× sample buffer containing 
50 mM DTT boiled, and subjected to SDS–PAGE using a MOPS 
gradient gel. Mass spectrometry was carried out on trypsin-digested 
gel bands as described above.
Norepinephrine uptake and secretion
PC12 cells grown to 80% confluence in poly-l-lysine–coated six-well 
plates were incubated with 1 μCi [3H] l-norepinephrine for 3 h, 
washed twice with release buffer, and then incubated for 15 min at 
37°C either in release buffer or in stimulation buffer. The supernatants 
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